^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CART-19/22

i
Other names: targeted CD19/CD22 chimeric antigen receptor engineered T cell immunotherapy, CART-19/22
Associations
Company:
Shanghai Unicar
Drug class:
CD19-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy
Related drugs:
Associations